Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
VETOQUINOL (GB:0O1O)
LSE:0O1O
VETOQUINOL (0O1O) Share Price & Analysis
0 Followers
0O1O Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€76.60 - €108.99
Previous Close€95.1
Volume92.00
Average Volume (3M)142.00
Market Cap
€1.12B
Enterprise Value€1.04B
Total Cash (Recent Filing)€93.71M
Total Debt (Recent Filing)€17.42M
Price to Earnings (P/E)20.3
Beta0.80
Next Earnings
Sep 12, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.84%
Share Statistics
EPS (TTM)4.70
Shares OutstandingN/A
10 Day Avg. Volume74
30 Day Avg. Volume142
Standard Deviation0.11
R-Squared0.01
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering1
0O1O FAQ
What was VETOQUINOL’s price range in the past 12 months?
VETOQUINOL lowest share price was €76.60 and its highest was €108.99 in the past 12 months.
What is VETOQUINOL’s market cap?
Currently, no data Available
When is VETOQUINOL’s upcoming earnings report date?
VETOQUINOL’s upcoming earnings report date is Sep 12, 2024 which is in 131 days.
How were VETOQUINOL’s earnings last quarter?
VETOQUINOL released its earnings results on Mar 20, 2024. The company reported €1.972 earnings per share for the quarter, beating the consensus estimate of N/A by €1.972.
Is VETOQUINOL overvalued?
According to Wall Street analysts VETOQUINOL’s price is currently Overvalued.
Does VETOQUINOL pay dividends?
VETOQUINOL does not currently pay dividends.
What is VETOQUINOL’s EPS estimate?
VETOQUINOL’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does VETOQUINOL have?
VETOQUINOL has 11,881,902 shares outstanding.
What happened to VETOQUINOL’s price movement after its last earnings report?
VETOQUINOL reported an EPS of €1.972 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -5.709%.
Which hedge fund is a major shareholder of VETOQUINOL?
Currently, no hedge funds are holding shares in GB:0O1O
---
VETOQUINOL Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
― (―)
― (―)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Fundamentals
Return on Equity
10.98%
Trailing 12-Months
Asset Growth
6.20%
Trailing 12-Months
Company Description
VETOQUINOL
Vetoquinol SA operates is a France-based firm serving in the healthcare market. Its focus lies on developing and marketing veterinary drugs mainly in the European region and to a certain extent in America and Asia. Its portfolio of drugs entails anti-infectives, anti- pain inflammatory drugs, cardiovascular and nephrology treatment intended mainly for pets and livestock.
---
Technical Analysis
---